NYSE:SNN Smith & Nephew - SNN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. $28.35 +0.03 (+0.11%) (As of 02/7/2023 09:39 AM ET) Add Compare Share Share Today's Range$28.29▼$28.3550-Day Range$26.03▼$29.0252-Week Range$21.77▼$36.14Volume13,444 shsAverage Volume648,194 shsMarket Capitalization$12.34 billionP/E RatioN/ADividend Yield1.93%Price TargetN/A ProfileAnalyst RatingsChartCompetitorsDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Smith & Nephew MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.59% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.68Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth8.28%From $1.57 to $1.70 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.63 out of 5 starsMedical Sector920th out of 1,027 stocksSurgical Appliances & Supplies Industry21st out of 23 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Smith & Nephew. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.59% of the float of Smith & Nephew has been sold short.Short Interest Ratio / Days to CoverSmith & Nephew has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Smith & Nephew has recently increased by 30.77%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldSmith & Nephew pays a meaningful dividend of 1.93%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSmith & Nephew does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Smith & Nephew will have a dividend payout ratio of 32.94% next year. This indicates that Smith & Nephew will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SNN. Previous Next 2.6 News and Social Media Coverage News SentimentSmith & Nephew has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Smith & Nephew this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for SNN on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Smith & Nephew to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Smith & Nephew insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.00% of the stock of Smith & Nephew is held by insiders.Percentage Held by InstitutionsOnly 9.11% of the stock of Smith & Nephew is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Smith & Nephew are expected to grow by 8.28% in the coming year, from $1.57 to $1.70 per share.Price to Earnings Growth RatioSmith & Nephew has a PEG Ratio of 3.09. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSmith & Nephew has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Smith & Nephew (NYSE:SNN) StockSmith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in Watford, the United Kingdom.Read More Receive SNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter. Email Address SNN Stock News HeadlinesFebruary 3, 2023 | americanbankingnews.comBrokerages Set Smith & Nephew plc (NYSE:SNN) Price Target at $1,486.00December 15, 2022 | marketwatch.comSmith & Nephew falls Thursday, underperforms marketFebruary 7, 2023 | Investing Trends (Ad)GRAPHITE: "Essential for America's National Defense"Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. November 5, 2022 | seekingalpha.comSmith & Nephew plc (SNN) Q3 2022 Earnings Call TranscriptOctober 12, 2022 | finance.yahoo.comPalm Valley Capital: “Smith & Nephew (SNN) is a High-Quality Business”October 11, 2022 | finance.yahoo.com10 Best International Stocks to Buy NowSeptember 26, 2022 | seekingalpha.comSmith & Nephew: Still A Buy Despite Short-Term ChallengesSeptember 16, 2022 | nasdaq.comFirst Week of November 18th Options Trading For Smith & Nephew (SNN)February 7, 2023 | Investing Trends (Ad)GRAPHITE: "Essential for America's National Defense"Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. September 14, 2022 | finance.yahoo.comSmith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder SurgerySeptember 14, 2022 | finance.yahoo.comNew randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 monthsAugust 9, 2022 | uk.finance.yahoo.comAnother day, another profits warning – but here's why you should stick by Smith & NephewAugust 5, 2022 | finance.yahoo.comIs There An Opportunity With Smith & Nephew plc's (LON:SN.) 36% Undervaluation?August 4, 2022 | finance.yahoo.comSmith+Nephew's OXINIUM™ Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekendJune 16, 2022 | msn.comPolitical leaders clash over Smith & Nephew move to leave HullJune 16, 2022 | bbc.comSmith & Nephew: Hull Labour group asks government to step inJune 14, 2022 | finance.yahoo.comSMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGSJune 9, 2022 | finanznachrichten.deSmith & Nephew plc: Smith+Nephew announces new UK R&D and manufacturing facility for Advanced Wound Management with $100m+ investment near HullJune 8, 2022 | finance.yahoo.comSmith+Nephew announces first total hip replacement cases on its CORI™ Surgical System using RI.HIP MODELER and RI.HIP NAVIGATIONJune 1, 2022 | seekingalpha.comSmith & Nephew sells 2 wound-healing cell therapies to HealivaJune 1, 2022 | seekingalpha.comSmith & Nephew: Fair Price For An Attractive Medical Devices SupplierApril 28, 2022 | seekingalpha.comSmith & Nephew reports Q1 resultsApril 4, 2022 | finance.yahoo.comShould Weakness in Smith & Nephew plc's (LON:SN.) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?March 31, 2022 | finance.yahoo.comForm 8.3 - SNN LN Equity 28-March-22 Dealing Disclosure (AMENDMENT)March 29, 2022 | finance.yahoo.comForm 8.3 - SNN LN Equity 28-March-22 Dealing DisclosureMarch 28, 2022 | finance.yahoo.comForm 8.3 - SNN LN Equity 25-March-22 Dealing DisclosureMarch 17, 2022 | uk.finance.yahoo.comTop investment tips for a stocks and shares ISASee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SNN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter. Email Address SNN Company Calendar Last Earnings11/17/2014Today2/07/2023Next Earnings (Estimated)2/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:SNN CUSIPN/A CIK845982 Webwww.smith-nephew.com Phone441923477100Fax44-20-7930-3353Employees18,000Year Founded1856Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio18.06 P/E Growth3.09Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.42 Current Ratio1.78 Quick Ratio0.84 Sales & Book Value Annual Sales$5.21 billion Price / Sales2.37 Cash Flow$2.85 per share Price / Cash Flow9.95 Book Value$12.66 per share Price / Book2.24Miscellaneous Outstanding Shares435,350,000Free Float430,995,000Market Cap$12.34 billion OptionableOptionable Beta0.59 Social Links Key ExecutivesDeepak S NathChief Executive Officer & DirectorPaul ConnollyPresident-Global OperationsAnne-Francoise NesmesChief Financial Officer & Executive DirectorIan MellingSenior Vice President-Corporate FinanceAlison ParkesChief Compliance OfficerKey CompetitorsEnovisNYSE:ENOVSTERISNYSE:STEAlign TechnologyNASDAQ:ALGNZimmer BiometNYSE:ZBHExact SciencesNASDAQ:EXASView All CompetitorsInsiders & InstitutionsScharf Investments LLCBought 18,039 shares on 2/6/2023Ownership: 0.479%Brinker Capital Investments LLCSold 1,150 shares on 2/6/2023Ownership: 0.003%Investors Research CorpBought 8,975 shares on 2/6/2023Ownership: 0.002%Ellevest Inc.Bought 1,321 shares on 2/3/2023Ownership: 0.001%Legacy Wealth Asset Management LLCSold 910 shares on 2/2/2023Ownership: 0.004%View All Institutional Transactions SNN Stock - Frequently Asked Questions Should I buy or sell Smith & Nephew stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares. View SNN analyst ratings or view top-rated stocks. How have SNN shares performed in 2023? Smith & Nephew's stock was trading at $26.89 at the beginning of 2023. Since then, SNN shares have increased by 5.3% and is now trading at $28.32. View the best growth stocks for 2023 here. Are investors shorting Smith & Nephew? Smith & Nephew saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 2,550,000 shares, an increase of 30.8% from the December 31st total of 1,950,000 shares. Based on an average daily volume of 808,400 shares, the days-to-cover ratio is currently 3.2 days. Currently, 0.6% of the company's shares are short sold. View Smith & Nephew's Short Interest. When is Smith & Nephew's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023. View our SNN earnings forecast. How were Smith & Nephew's earnings last quarter? Smith & Nephew plc (NYSE:SNN) released its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.59. How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew? Smith & Nephew declared a semi-annual dividend on Monday, August 1st. Stockholders of record on Friday, September 30th will be paid a dividend of $0.288 per share on Wednesday, October 26th. This represents a dividend yield of 2.8%. The ex-dividend date is Thursday, September 29th. Read our dividend analysis for SNN. Is Smith & Nephew a good dividend stock? Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.55 per share and currently has a dividend yield of 1.93%. Read our dividend analysis for SNN. What other stocks do shareholders of Smith & Nephew own? Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN). What is Smith & Nephew's stock symbol? Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN." Who are Smith & Nephew's major shareholders? Smith & Nephew's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Scharf Investments LLC (0.48%), Bank of Montreal Can (0.08%), National Bank of Canada FI (0.05%), Clean Yield Group (0.04%), Henry James International Management Inc. (0.04%) and Canvas Wealth Advisors LLC (0.02%). How do I buy shares of Smith & Nephew? Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Smith & Nephew's stock price today? One share of SNN stock can currently be purchased for approximately $28.32. How much money does Smith & Nephew make? Smith & Nephew (NYSE:SNN) has a market capitalization of $12.33 billion and generates $5.21 billion in revenue each year. How many employees does Smith & Nephew have? The company employs 18,000 workers across the globe. How can I contact Smith & Nephew? Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353. This page (NYSE:SNN) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.